WHO ICTRP trial
Efficacy and safety of trazodone OAD and venlafaxine XR in the treatment of…
EUCTR2011-005878-37-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-005878-37-IT |
|---|---|
| Public title | Efficacy and safety of trazodone OAD and venlafaxine XR in the treatment of Major Depressive Disorder |
| Scientific title | A randomized, double-blind study comparing the efficacy and safety of trazodone OAD and venlafaxine XR in the treatment of patients with Major Depressive Disorder - trazodone OAD in MDD |
| Primary sponsor | ANGELINI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Czech Republic;Austria;Italy |
| Conditions | Major Depressive Disorder MedDRA version: 14.1 Level: HLGT Classification code 10012375 Term: Depressed mood disorders and disturbances System Organ Class: 10037175 - Psychiatric disorders MedDRA version: 14.1 Level: SOC Classification code… |
| Interventions | Product Name: Trazodone HCl containing Contramid® prolonged release tablets Product Code: 039(C) Pharmaceutical Form: Prolonged-release tablet INN or Proposed INN: TRAZODONE HYDROCHLORIDE CAS Number: 25332-39-2 Current Sponsor code: 039… |
| Registration date | Dec 6, 2012 |
| Target size | 360 |
| Secondary IDs | 039(C)SC11063 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: